FindTrial
Sign In

Follitropin delta

DRUG14 trials

Sponsors

Ferring Pharmaceuticals, Clinique Ovo, Peter Kovacs MD, University of Luebeck

Conditions

Controlled Ovarian SimulationControlled Ovarian StimulationFertilityIVFInfertilityInfertility, FemaleIntrauterine InseminationOvarian Dysfunction

Phase 1

Rekovelle PK Trial in Chinese Women
CompletedNCT04150861
Ferring PharmaceuticalsInfertility
Start: 2019-06-23End: 2019-12-16Updated: 2023-02-14
An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation
TerminatedNCT06466486
Ferring PharmaceuticalsFertility
Start: 2024-06-14End: 2025-12-03Updated: 2026-03-30
An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.
TerminatedNCT06511791
Ferring PharmaceuticalsInfertility
Start: 2024-07-15End: 2025-10-16Updated: 2026-03-30

Phase 2

Personalized Insemination Treatment Study
CompletedNCT03830723
Clinique OvoInfertility, Intrauterine Insemination, Reproduction
Start: 2020-01-09End: 2021-09-27Updated: 2022-09-13

Phase 3

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women
CompletedNCT03228680
Ferring PharmaceuticalsInfertility
Start: 2017-07-29End: 2019-07-08Updated: 2023-08-24
Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women
CompletedNCT03296527
Ferring PharmaceuticalsControlled Ovarian Simulation
Start: 2017-12-01End: 2020-07-26Updated: 2023-08-24
Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2)
CompletedNCT03738618
Ferring PharmaceuticalsInfertility, Female
Start: 2018-10-29End: 2020-12-21Updated: 2024-01-18
Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1)
CompletedNCT03740737
Ferring PharmaceuticalsInfertility
Start: 2018-10-26End: 2020-11-11Updated: 2024-01-18

Unknown Phase

Study to Assess the Patterns of Use of REKOVELLE® in Naïve Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures
CompletedNCT03393780
Ferring PharmaceuticalsControlled Ovarian Stimulation
Start: 2018-03-16End: 2020-07-17Updated: 2023-02-09
Impact of Blastocyst Morphological Development and Blastocoele Re-expansion on Pregnancy Outcome After Using REKOVELLE®
TerminatedNCT03697031
Ferring PharmaceuticalsControlled Ovarian Stimulation
Start: 2018-09-01End: 2020-12-31Updated: 2023-12-12
Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice
CompletedNCT04503707
Ferring PharmaceuticalsControlled Ovarian Stimulation
Start: 2020-06-17End: 2021-10-31Updated: 2021-12-14
Cumulative Pregnancy Rate With Lower and Higher Gonadotropin Dose During IVF Among Poor Responders
CompletedNCT05103228
Peter Kovacs MDInfertility, Ovarian Dysfunction
Start: 2021-12-02End: 2023-07-20Updated: 2024-12-13
Real-world Evidence on Follitropin Delta Individual Dosing
RecruitingNCT05173597
University of LuebeckInfertility, Sterility
Start: 2021-12-08End: 2026-03-31Target: 850Updated: 2025-03-30
Retrospective Study of High Dose Follitropin Delta in a Mixed Protocol With Human Chorionic Gonadotropin
CompletedNCT05873725
Clinique OvoInfertility, IVF
Start: 2023-05-20End: 2024-03-19Updated: 2025-12-09

Related Papers

Cost-Effectiveness of Follitropin Delta Compared with Follitropins Alfa and Beta in Controlled Ovarian Stimulation for Assisted Reproductive Technologies (ART) in France.
2026-03-11
Ovarian stimulation with follitropin delta is safe and effective: results from the RITA randomized, double-blind, placebo-controlled trials.
2025-07-241 citations
P-643 When low serum AMH and high body weight converge: Is the algorithm-mandated first IVF-cycle maximum follitropin delta dose of 12 µg/d optimizing oocyte yield?
Human Reproduction2025-06-01
O-014 Cumulative live birth associated with number of oocytes in ovarian stimulation with follitropin delta: an individual patient data meta-analysis
Human Reproduction2024-07-01
P-680 Comparison of ovarian hyperstimulation syndrome (OHSS) rates resulting from conventional dosing versus personalized dosing of follitropin delta in ovarian stimulation, analysis of RITA, ESTHER-1 trials
Human Reproduction2024-07-01
O-013 Population pharmacokinetics of follitropin delta during ovarian stimulation
Human Reproduction2024-07-01
P-655 Live birth rate in the fresh cycle associated with number of oocytes in ovarian stimulation with individualised follitropin delta: an individual patient data meta-analysis
Human Reproduction2024-07-01
Pharmacokinetics and Safety of Follitropin Delta in Gonadotropin Down-Regulated Healthy Chinese Women
Clinical Drug Investigation2022-12-078 citations
Comparative clinical outcome following individualized follitropin delta dosing in Chinese women undergoing ovarian stimulation for in vitro fertilization /intracytoplasmic sperm injection
Reproductive Biology and Endocrinology2022-10-0414 citations
P-788 A proof-of-concept study evaluating the effect of personalized dosages of follitropin delta in intra-uterine insemination (IUI): Personalized IUI Treatment Study (PITS)
Human Reproduction2022-06-29
P-143 The initial blastocyst size after warming is a strong predictor for clinical pregnancy in single vitrified blastocyst transfer
Human Reproduction2022-06-29
O-011 A prospective multicentre, non-interventional, real-world study to assess the pattern of use, effectiveness and safety of follitropin delta in routine clinical practice (the PROFILE study)
Human Reproduction2022-06-29
Comparison of ovarian response to follitropin delta in Japanese and White IVF/ICSI patients.
2021-09-234 citations
O-114 Improved safety and efficiency of individualised versus conventional gonadotropin dosing for ovarian stimulation in IVF/ICSI: an individual patient meta-analysis (IPD-MA)
Human Reproduction2021-07-013 citations
P–650 Body weight is the main determinant of systemic follicle stimulating hormone (FSH) concentrations during controlled ovarian stimulation with follitropin delta
Human Reproduction2021-07-013 citations
O-110 A randomised, controlled, assessor-blind trial assessing clinical outcomes of individualised dosing with follitropin delta in Asian IVF/ICSI patients
Human Reproduction2021-07-01
A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF/ICSI patients
Human Reproduction2021-06-0365 citations